Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MJardin Group Inc MJARF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
MJardin Group is a cannabis management platform with extensive experience in cultivation, processing, distribution, and retail. For over 10 years, MJardin Group has refined cultivation methodologies, developed state of the art facilities, and implemented vertical integration for and on behalf of license owners. MJardin Group currently owns, manages or advises on a portfolio of 32 cannabis operations.


GREY:MJARF - Post by User

MJardin Group Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by MakingIton Jan 20, 2019 7:26pm
127 Views
Post# 29257752

coil spring waiting for earnings report

coil spring waiting for earnings reportThe more I break down this stock the more it becomes one of my favorites. Seems like a coil spring ready to let loose. Compare it's tiny market cap to others with similar revenue estimates, perhaps one of the best value plays out there right now.

Can anyone give any reasons why NOT to invest in MJAR?? This board seems a bit dead compared to others cannabis companies... what is not to like about mjardin? Im seeing revenue estmates similar to OGI/FIRE/TRST, so why are people not jumping all over this one with such a tiny market cap?

Im a former FX trader, so Im thinking maybe Im missing some fundemental element.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities